Join
Live feed
·
PRReleasevia Quantisnow
Omega Therapeutics Inc. logo

Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial

ByQuantisnow·Wall Street's wire, on your screen.
OMGA· Omega Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OMGA (Omega Therapeutics Inc.) and more on Quantisnow.